Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Randomized,Double Blind,Placebo Controlled Trial of Myocardial Angiogenesis Using VEGF165, Intramyocardial Gene Delivery in Patients With Severe Angina

NCT00143585 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT00143585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00143585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Randomized,Double Blind,Placebo Controlled Trial of Myocardial Angiogenesis Using VEGF165, Intramyocardial Gene Delivery in Patients With Severe Angina
Lead sponsor
Unity Health Toronto
Phase
Phase 2/3
Overall status
Unknown status
Start date
June 30, 2002
Completion date
June 30, 2007
Enrollment
120
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial ischemia